Vizgen showcases cellular and subcellular tumor characterization with new PanCancer Pathways Panel
18 Apr 2023
At the American Association for Cancer Research (AACR) 2023 Annual Meeting in Florida, USA Vizgen, launched the MERSCOPE® PanCancer Pathways Panel.
The PanCancer Pathways Panel features a list of genes targeting canonical signaling pathways of cancer and is constructed using recognized oncology databases including OncoKB®, MutSig, the Cancer Genome Atlas, and Hallmarks of Cancer to ensure the inclusion of critical cancer genes. The Panel provides a key tool for researchers to study tumor behavior at cellular and subcellular levels across multiple different types of cancers.
The PanCancer Pathways Panel features:
- Characterization of major oncology signaling pathways including RAS/RTK, PI3K, NOTCH, MYC, Cell Cycle, HIPPO
- Inclusion of cell type markers to identify healthy and disease states
- Compatibility across multiple cancer types
Vizgen also showcased data generated using the new MERSCOPE PanCancer Pathways Panel. The data demonstrates the ability of the MERSCOPE Platform to characterize individual cells in a wide range of human tumor types, including breast, colon, prostate, ovarian, lung and liver cancers. Analysis of expression patterns in tumor cells highlights the panels’ ability to accurately reproduce known transcriptional signatures of hepatocellular carcinoma.
“While Vizgen is known for the customizability of our platform, this pre-designed panel along with our PanNeuro Cell Type Panel represent an ideal starting point for researchers who are looking for convenient off-the-shelf options to explore adding spatial genomic capabilities into their research,” said Terry Lo, President and CEO of Vizgen.
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>